Skip to content

Trump identifies these nations - such as Pakistan and Afghanistan - as significant drug-producing and transit countries; is India mentioned?

Trump designates 23 countries, among them India, as key drug trafficking routes or illicit drug production sites. Through a 'Presidential Determination,' Trump shared his assertions with Congress.

Major drug-producing and transit nations as identified by Donald Trump encompass nations such as...
Major drug-producing and transit nations as identified by Donald Trump encompass nations such as Pakistan and Afghanistan, but does India make the list?

Trump identifies these nations - such as Pakistan and Afghanistan - as significant drug-producing and transit countries; is India mentioned?

In a significant move, US President Donald Trump has formally listed 22 countries, including India, Pakistan, Afghanistan, Burma, the Bahamas, Belize, Bolivia, China, Colombia, Costa Rica, the Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Laos, Mexico, Nicaragua, Panama, Peru, and Venezuela, as major drug transit or illicit drug-producing nations.

The President's claims were presented through a 'Presidential Determination' to Congress, but no specific details were given about the timeline of this announcement or the criteria used to determine these countries' involvement in drug trafficking.

Trump specifically highlighted the high level of drug production and trafficking from Afghanistan, even when the country has put a mandatory ban. Fentanyl and other synthetic painkillers were cited as being behind the health crisis in the US. However, no specific details were provided about the role of India in drug trafficking, or any mention was made of Trump's views on India's involvement.

The White House has officially tagged these countries as responsible for procuring and transporting illegal drugs into the US. The production and smuggling of illegal drugs and intermediate chemicals from these countries were said to pose a threat to US security.

Trump designated Afghanistan as having failed demonstrably to uphold its drug control obligations, citing the serious threats to US interests and international security. Some members of the Taliban were reported to still be profiting from this trade.

The US State Department stated that geographic, commercial, and economic factors can allow drugs or precursor chemicals to be transited or produced, even in countries with robust narcotics control and law enforcement measures.

No details were given about any domestic efforts to combat drug trafficking in the US or these listed countries, and no mention was made of any international cooperation or response to this announcement. Furthermore, no information was provided about any potential consequences for these countries as a result of this listing.

Read also:

Latest